Just to add to this, I think ENOX2 is tumour-specific, so even if idronoxil has off-target effects these effects will most likely be confined to tumour tissues and not healthy tissues, making it ideal for treating cancer.
BMS woes continue, page-10
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $33.60M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 33616 | 1 |
View Market Depth
| Last trade - 16.12pm 08/10/2024 (20 minute delay) ? |
| NOX (ASX) Chart |
Day chart unavailable